Dupilumab: One therapy to treat multiple atopic diseases

Dupilumab: One therapy to treat multiple atopic diseases

Bibliographic Details
Main Authors:	Fatima Bawany, BA, Abigail I. Franco, MD, Lisa A. Beck, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	JAAD Case Reports
Subjects:	allergic rhinitis asthma atopic dermatitis chronic sinusitis dupilumab eosinophilic esophagitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512620306470

Similar Items

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
by: Marco Dubini, et al.
Published: (2023-09-01)

New Directions in Understanding Atopic March Starting from Atopic Dermatitis
by: Nunzia Maiello, et al.
Published: (2022-03-01)

The Prevalence of Atopic Dermatitis in Adults and its Association with Respiratory Allergic Disorders in Bushehr City, Iran
by: Amir Hossein darabi, et al.
Published: (2021-03-01)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
by: Federica Gelato, et al.
Published: (2023-03-01)

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
by: Sandra Ferreira, et al.
Published: (2020-05-01)

Eosinophilic pneumonia developed after dupilumab administration in a patient with atopic dermatitis
by: Kei Kanata, et al.
Published: (2023-08-01)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018-03-01)

Dupilumab side effect in a patient with atopic dermatitis: a case report study
by: Albader SS, et al.
Published: (2019-05-01)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
by: Yolanka Lobo, et al.
Published: (2021-05-01)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
by: Maria Esposito, MD, et al.
Published: (2023-01-01)

Injection site reactions after dupilumab or tralokinumab for atopic dermatitis
by: Fabrizio Martora, et al.
Published: (2024-12-01)

Conjunctivitis as a common adverse effect of dupilumab in atopic dermatitis
by: Mikołaj Cichoń, et al.
Published: (2023-03-01)

Trends (2007–2019) of major atopic diseases throughout the life span in a large Mexican population
by: Martín Becerril-Ángeles, M.D., et al.
Published: (2023-01-01)

Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series
by: Shuhei Hara, MD, et al.
Published: (2023-05-01)

Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease
by: Silvia Ferrucci, et al.
Published: (2022-07-01)

A case of infective endocarditis associated with atopic dermatitis perioperatively treated with dupilumab
by: Mika Nakanishi, et al.
Published: (2019-10-01)

Neurotrophins: Neuroimmune Interactions in Human Atopic Diseases
by: Tobias Weihrauch, et al.
Published: (2023-03-01)

Dupilumab for atopic dermatitis treatment: A single-center retrospective study
by: Gülbin Yaşar, et al.
Published: (2022-03-01)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
by: Deng L, et al.
Published: (2022-11-01)

Association between atopic disease and anemia in pediatrics: a cross-sectional study
by: Kiyon Rhew, et al.
Published: (2019-11-01)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
by: Ceryn J, et al.
Published: (2021-08-01)

Vitiligo during dupilumab therapy
by: Vincenzo Picone, MD, et al.
Published: (2023-06-01)

Research Progress in Atopic March
by: Lan Yang, et al.
Published: (2020-08-01)

The Prevalence of Allergic Rhinitis, Allergic Conjunctivitis, Atopic Dermatitis and Asthma among Adults of Tehran
by: Raheleh SHOKOUHI SHOORMASTI, et al.
Published: (2018-11-01)

Dupilumab-induced pityriasis rosea in a 28-year-old male with atopic dermatitis
by: Faraz Yousefian, DO, et al.
Published: (2024-03-01)

Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2020-07-01)

Atopic March or Atopic Multimorbidity—Overview of Current Research
by: Iva Mrkić Kobal, et al.
Published: (2023-12-01)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
by: Andreas Wollenberg, et al.
Published: (2022-05-01)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
by: Shan J, et al.
Published: (2022-11-01)

Dupilumab for the treatment of moderate and severe atopic dermatitis: real-life experience
by: Jowita Sroka-Tomaszewska, et al.
Published: (2024-01-01)

Cytokine Levels and Neuropsychological Function among Patients with Attention-Deficit/Hyperactivity Disorder and Atopic Diseases
by: Shung-Jie Chang, et al.
Published: (2022-07-01)

Associative factors for atopic dermatitis and other atopic diseases in middle‐aged adults: A population‐based birth cohort study among 5373 subjects
by: Anna K. Haarala, et al.
Published: (2023-01-01)

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
by: Liu L, et al.
Published: (2023-08-01)

Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab
by: George G. Mitroi, et al.
Published: (2022-10-01)

Ten-Year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008–2017
by: Jihyun Ha, et al.
Published: (2020-07-01)

Dupilumab Treatment Efficacy and Impact on Clinical Scores, Serum Biomarkers, and Itch in Adult Patients with Atopic Dermatitis: A Retrospective Analysis
by: Rossi M, et al.
Published: (2023-11-01)

Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
by: Paweł Iwańczuk
Published: (2024-02-01)

Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
by: Silvia Ferrucci, et al.
Published: (2023-10-01)

Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
by: T. Torres, et al.
Published: (2022-07-01)